Archives

All posts by Cited in article

Register HERE today!

Harris Bricken litigators regularly advise cannabis and hemp businesses, investors and third parties at all stages of dispute resolution. Our expertise ranges from pre-filing resolution and mediation through motion practice, arbitration and open court. We regularly defend clients in administrative and license cancellation proceedings as well.

Cannabis disputes are unique. They are typically more complex than disputes found in other industries and they are nearly always “bet the business” affairs. Over the years, we have developed and prosecuted successful litigation strategies for many California, Oregon and Washington clients.

On Wednesday, August 5, 2020, Harris Bricken’s litigators will discuss recent trends in cannabis litigation. We will answer your questions on this complex and evolving area of the law. The panel will consist of attorneys Jihee Ahn (Los Angeles and Portland) and Jesse Mondry (Portland), and will be moderated by Griffen Thorne (Los Angeles).

This presentation is free to attend and we encourage all attendees to submit questions in advance while registering. The attorneys will answer as many as possible during the lunch hour.

Register HERE today for our upcoming FREE webinar at 12pm PDT on Wednesday, August 5, 2020.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Argentina podría acaparar el mercado multimillonario de la marihuana y generar miles de puestos de trabajo, cosas urgentes para nuestra golpeada economía.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

I used to dream of being a normal mother. I would see other mums dropping their kids off at school, waving them goodbye and I’d want to be them. Not the parent with a chronically ill child.

For years, this scenario felt unattainable, but since my son Alfie Dingley became the first patient in the UK to receive a permanent cannabis licence, our family has been given hope.

There’s a lot of fear around the word ‘cannabis’. But for Alfie and my family, it changed our lives.

When he was five years old, my son was diagnosed with a rare form of epilepsy, called PCDH19, which caused up to 150 seizures a month.

– Read the entire article at Metro News.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Ben Emerson had never tried cannabis edibles before his birthday in April. He was raised in the Evangelical Presbyterian Church, which he left five years ago, and marijuana was “this thing that I had never really even thought that I was allowed to do,” he said.

“And then I’m like, ‘Wait, I can actually make up my own mind about this.’”

For his first foray, Mr. Emerson, 38, chose strawberry-flavored gummies, which he ordered online and picked up curbside at a dispensary near his home in Portland, Ore. “I’m not super-interested in smoking anything,” he said. “But as soon as I decided I wanted to try cannabis, I wanted to try something edible.”

– Read the entire article at The New York Times.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

The World Health Organization (WHO) wasn’t a household name. That was, until it became the subject of public health and political controversy surrounding the COVID-19 pandemic. Aside from mitigating global pandemics, the WHO plays a significant role in the consideration of cannabis as a controlled substance on a global basis through the United Nations (UN). In January 2019, the WHO expressly recommended that cannabis be rescheduled and also provided clarity to its treatment of cannabinoids, like CBD. While the UN has delayed taking action on the recommendation, it begs the question of whether or not we’re on the verge of global cannabis policy reform.

The Single Convention on Narcotic Drugs of 1961 is an international treaty prohibiting production and supply of specific drugs and of drugs with similar effects — except under governmental license for specific purposes, such as medical treatment and research.

– Read the entire article at Forbes.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

The new certificate program will focus on the pharmacology of pot.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Four medical cannabis companies in The Garden State are planning to begin delivery services.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Israel is among the world’s leaders in the medical and non-medical cannabis research and development (R&D). Israeli scientists made breakthrough discoveries in the mid-twentieth century, paving the way for the country being one of the early adopters of a medical cannabis program. Now, Israel is gearing up to legalize recreational cannabis and export cannabis across the globe and become one of the leading nations in the global cannabis trade. In this post, I briefly examine the history of cannabis in Israel and what the future may hold for the country.

While cannabis has been used for thousands of years in ancient sites in Israel, the country’s developments in the last few decades have been extremely significant. In the 1960s, Israeli chemist Raphael Mechoulam began making breakthroughs in researching cannabis, becoming the first researcher to isolate the THC compound. Fast forwarding a few decades, in the 1990s, the Israeli government began researching and studying potential reforms for cannabis in Israel.

Cannabis in Israel has long been regulated under the Dangerous Drugs Ordinance as a dangerous drug (sort of like cannabis in the US and the Controlled Substances Act). Nevertheless, the first medical cannabis authorizations were allowed in Israel in the

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

A cross-party group of MPs has written to Health Secretary Matt Hancock demanding action.

Health Secretary Matt Hancock was tonight urged to tear up red tape campaigners say is hampering prescriptions of medical cannabis for children with rare epilepsy.

There have been no new NHS prescriptions for full-extract cannabis oil since the medicinal use of the drug was legalised more than 18 months ago, it emerged this month.

Experts say strict guidelines make it difficult to get hold of the treatment on the NHS.

– Read the entire article at Mirror.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

The Canadian cannabis sector was absolutely savaged in 2019 as fundamental issues with demand and sky-high expectations from retail investors collided.

With the hot air largely out of Canadian cannabis stocks by year-end, investors started buying many of the beaten-down names in early 2020 expecting the next few months to be the bottom before a multi-year uptrend began.

Things haven’t worked out as expected so far and with the release of new data from Health Canada, we now know why.

– Read the entire article at Grizzle.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest